Sartorius Stedim stock holds below EUR 190 before Q3 results
Published on 09/19/2026 at 16:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sartorius Stedim stock (FR0013154002) closed at EUR 189.60 on Euronext Paris on September 9, 2026, down 0.42 percent from EUR 190.40 the day before, with 10,315 shares traded.
Price stays near EUR 190
The same MarketScreener snapshot put the stock 4.2 percent below the EUR 198.60 level reached earlier in September 2026, which keeps the short-term chart tight around the EUR 190 mark.
Sartorius Stedim Biotech S.A. belongs to the Health Care / Biotechnology equipment segment, and the quoted Paris move gives investors a dated reference point for trading conditions on September 9, 2026.
Q3 results are next
As Ad hoc News reported on September 18, 2026, the stock was still trading below EUR 190 ahead of Q3 results, and the same report said consensus revenue expectations for 2026 and 2027 remain in the billion-euro range.
For investors, that leaves the next report as the key test: the share price is already priced against a September 9, 2026 closing level of EUR 189.60, while the consensus backdrop still points to large-scale revenue generation.
Market snapshot
At EUR 189.60 on September 9, 2026, the stock was trading below the EUR 198.60 level cited earlier in September 2026 and roughly in the upper half of that recent range.
Sartorius Stedim stock facts
- Company: Sartorius Stedim Biotech S.A.
- ISIN: FR0013154002
- Ticker: DIM.PA
- Trading venue: Euronext Paris
- Price (as of September 9, 2026, 15:48): EUR 189.60
- Sector / Industry: Health Care / Biotechnology equipment
